In the last decade, significant advances have been made in Glioblastoma Multiforme treatment with the novel use of alternating electrical fields, also termed as tumour treating fields (TTFs). This modality has shown promising results in recurrent and newly diagnosed GBM patients, and according to some, may soon be considered an addition to the previously known 'trifecta' of GBM standard of care, i.e., surgery, chemo and radiation therapy.Here we review the existing data on TTF for both recurrent and newly diagnosed GBM. This review does not discuss the limitations of TTF, especially from compliance and cost point of view.
JPMA. The Journal of the Pakistan Medical Association
(2018). Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme. JPMA. The Journal of the Pakistan Medical Association, 68(10), 1543-1545.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_neurosurg/156
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License